-
Olesen and associates report on a phase II study of BIBN 4096 to evaluate the safety and efficacy of a first in class non-peptide, parenteral CGRP-receptor antagonist.
-
In order to identify risk factors for CNS ischemic complications at presentation and during follow-up, Nesher and associates reviewed the charts of 175 patients with giant cell arteritis diagnosed between 1980 and 2000 at 4 Jerusalem hospitals.
-
Cardiac surgery may be complicated by ischemic stroke as well as more non-specific cognitive disturbances. Could prophylactic neuroprotective strategies be employed?
-
New-onset leg weakness or numbness is a common cause for neurologic consultation following gynecologic surgery.
-
A large cohort study from Denmark suggests no link between childhood vaccines and type 1 diabetes.
-
-
Physical symptoms are quite common among patients with depression. These symptoms tend to improve during the first month of therapy with serotonin-antagonists. Most symptoms will plateau in months to follow.
-
Esophageal adenocarcinoma (EAC), GERD, and Barretts esophagus (BE) are all on the rise, and there is no doubt that BE is a major risk factor for EAC. However, many unanswered questions surround screening GERD patients for BE and cancer.
-
The FDA has approved a low dose estradiol transdermal patch for prevention of osteoporosis in menopausal women.
-
Folate Therapy and In-Stent Restenosis and Coronary Stenting; Quinapril Reduces Markers of Oxidative Stress in the Metabolic Syndrome; Donepezil in Patients with Alzheimers